Home / Pharma Healthcare / United States mAb Biosimilar Market Report 2016

United States mAb Biosimilar Market Report 2016

  • Id : RNR-22967
  • Category : Pharma Healthcare
  • Publish Date : 12-Oct
  • Pages : 111
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of mAb Biosimilar
Revenue, means the sales value of mAb Biosimilar

This report studies sales (consumption) of mAb Biosimilar in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Baxter
    GSK
    Merck
    Novartis
    Pfizer
    Roche Holding
    Sanofi
    Mitsubishi Tanabe Pharma
    Hospira
    Alvartis Pharma
    Allergan
    Amega Biotech
    Biogen
    LG Lifesciences
    Samsung Biologics 

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by applications, this report focuses on sales, market share and growth rate of  mAb Biosimilar in each application, can be divided into
    Application 1
    Application 2
    Application 3